𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma

✍ Scribed by T.J. Postma; C.J. van Groeningen; R.J.G.M. Witjes; J.G.E. Weerts; J.H. Kralendonk; J.J. Heimans


Book ID
110230361
Publisher
Springer US
Year
1998
Tongue
English
Weight
294 KB
Volume
38
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Dose-intensification of procarbazine, CC
✍ Jakacki, Regina I.; Jamison, Cheryl; Mathews, Vincent P.; Heilman, Douglas K.; D πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 512 KB

Background. The regimen of procarbazine, CCNU, and vincristine is active against gliomas. Previous attempts at dose-intensification have been unsuccesful because of delayed and cumulative myelosuppression. We sought to determine whether peripheral blood stem cell (PBSC) infusions would allow dose-es

Second-line treatment with carboplatin f
✍ Riccardo Soffietti; Mauro Nobile; Roberta RudΓ ; Marzia Borgognone; Alessandra Co πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract ## BACKGROUND The efficacy of second‐line chemotherapy for patients with recurrent or progressive oligodendroglial tumors is limited. In the current study, the authors investigated the use of carboplatin as a second‐line chemotherapeutic agent against these types of tumors. ## METHODS